Search
| GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
|---|---|---|---|---|---|
| finn-b-C3_SECONDARY_NAS_EXALLC | 2021 | Secondary malignant neoplasm of other and unspecified sites (all cancers excluded) | NA | — | 16,380,303 |
| finn-b-PD2ND | 2021 | Secondary parkinsonism | NA | — | 16,380,459 |
| finn-b-PD2ND_EXMORE | 2021 | Secondary parkinsonism (more controls excluded) | NA | — | 16,379,412 |
| finn-b-G6_PARKSCND | 2021 | Secondary parkinsonism+Parkinsonism in other disease | NA | — | 16,380,453 |
| finn-b-D3_SCNDPOLYCYTHAEMIA | 2021 | Secondary polycythaemia | NA | — | 16,380,463 |
Data overview
The GWAS summary datasets information is not available at this time.